When does Moderna (MRNA) report earnings?
Moderna (MRNA) is scheduled to report earnings on November 4, 2026, before the US market opens — that is in 77 days. Consensus EPS estimate is $-1.22.
Because MRNA trades on Perplo as a perpetual future rather than a share, the market stays open through the print — including an after-close report, when the stock itself cannot be traded until the next session.
Last 4 reported quarters
| Quarter | EPS | Estimate | Result |
|---|---|---|---|
| 2026-06-30 | $-1.97 | $-2.12 | beat by $0.15 |
| 2026-03-31 | $-3.40 | $-4.04 | beat by $0.64 |
| 2025-12-31 | $-2.11 | $-2.70 | beat by $0.59 |
| 2025-09-30 | $-0.51 | $-2.15 | beat by $1.64 |